Rare Disease Report

CDER's Janet Woodcock Discusses the Future of Drug Development

OCTOBER 22, 2015
Janet Woodcock, MD



In an exclusive interview with Rare Disease Report, Janet Woodcock, MD, Director of the Center of Drug Evaluation and Research (CDER) at the US Food and Drug Administration (FDA) talks about the future of drug development, including the use of telemedicine and disease models.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.